709 filings
EFFECT
SLS
SELLAS Life Sciences Group Inc
2 May 24
Notice of effectiveness
12:16am
EFFECT
SLS
SELLAS Life Sciences Group Inc
2 May 24
Notice of effectiveness
12:16am
ARS
2023 FY
SLS
SELLAS Life Sciences Group Inc
29 Apr 24
Annual report to shareholders
5:54pm
DEFA14A
SLS
SELLAS Life Sciences Group Inc
29 Apr 24
Additional proxy soliciting materials
4:11pm
D
kp87z0b3
29 Mar 24
$18.37 mm in options / securities to be acquired, sold $18.37 mm, 4 investors
4:00pm
8-K
0x0dwgblls
28 Mar 24
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
rsus61am3r83 9h
28 Mar 24
Other Events
8:45am
424B5
y1mp s9u3l7t19g
18 Mar 24
Prospectus supplement for primary offering
4:37pm
8-K
uy57wornde8y1
15 Mar 24
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
4:29pm
8-K
i4s60 l9wyny8fb
11 Mar 24
Other Events
4:05pm
8-K
eqpybc
8 Mar 24
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
4:05pm
8-K
xm5jwe 1l1immo6
5 Mar 24
Other Events
4:01pm
8-K
bsl7tigi
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
S-8
9lc9l
19 Jan 24
Registration of securities for employees
4:11pm
8-K
xwfkpgq960lq t46
8 Jan 24
SELLAS Life Sciences Announces Pricing of $9.0 Million Public Offering
5:07pm